vs

Side-by-side financial comparison of Immunocore Holdings plc (IMCR) and Purple Innovation, Inc. (PRPL). Click either name above to swap in a different company.

Purple Innovation, Inc. is the larger business by last-quarter revenue ($140.7M vs $104.5M, roughly 1.3× Immunocore Holdings plc). On growth, Immunocore Holdings plc posted the faster year-over-year revenue change (24.3% vs 9.1%). Purple Innovation, Inc. produced more free cash flow last quarter ($-7.8M vs $-35.5M). Over the past eight quarters, Immunocore Holdings plc's revenue compounded faster (21.7% CAGR vs 8.3%).

Immunocore is a global commercial-stage biotechnology company, based in Oxfordshire, which researches and develops biological drugs using soluble T-cell receptor technology.

Purple Carrot is a Needham, Massachusetts-based, and 100% plant-based meal kit company. Founded by Andy Levitt, it offers both prepared meals as well as meal kits to subscribers weekly. As stated in a 2022 article in Cosmopolitan, “each Purple Carrot meal kit results in 72% less carbon being released into the atmosphere as compared to the standard American meal.”

IMCR vs PRPL — Head-to-Head

Bigger by revenue
PRPL
PRPL
1.3× larger
PRPL
$140.7M
$104.5M
IMCR
Growing faster (revenue YoY)
IMCR
IMCR
+15.2% gap
IMCR
24.3%
9.1%
PRPL
More free cash flow
PRPL
PRPL
$27.7M more FCF
PRPL
$-7.8M
$-35.5M
IMCR
Faster 2-yr revenue CAGR
IMCR
IMCR
Annualised
IMCR
21.7%
8.3%
PRPL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
IMCR
IMCR
PRPL
PRPL
Revenue
$104.5M
$140.7M
Net Profit
$-3.2M
Gross Margin
97.4%
41.9%
Operating Margin
-18.8%
-1.6%
Net Margin
-2.3%
Revenue YoY
24.3%
9.1%
Net Profit YoY
62.1%
EPS (diluted)
$-0.61
$0.03

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
IMCR
IMCR
PRPL
PRPL
Q4 25
$104.5M
$140.7M
Q3 25
$103.7M
$118.8M
Q2 25
$98.0M
$105.1M
Q1 25
$93.9M
$104.2M
Q4 24
$84.1M
$129.0M
Q3 24
$80.2M
$118.6M
Q2 24
$75.4M
$120.3M
Q1 24
$70.5M
$120.0M
Net Profit
IMCR
IMCR
PRPL
PRPL
Q4 25
$-3.2M
Q3 25
$-177.0K
$-11.7M
Q2 25
$-10.3M
$-17.3M
Q1 25
$5.0M
$-19.1M
Q4 24
$-8.5M
Q3 24
$8.7M
$-39.2M
Q2 24
$-11.6M
$27.0K
Q1 24
$-24.4M
$-50.2M
Gross Margin
IMCR
IMCR
PRPL
PRPL
Q4 25
97.4%
41.9%
Q3 25
99.5%
42.8%
Q2 25
98.9%
35.9%
Q1 25
99.1%
39.4%
Q4 24
99.6%
42.9%
Q3 24
99.4%
29.7%
Q2 24
97.7%
40.7%
Q1 24
99.7%
34.8%
Operating Margin
IMCR
IMCR
PRPL
PRPL
Q4 25
-18.8%
-1.6%
Q3 25
-6.9%
-10.2%
Q2 25
-15.2%
-13.5%
Q1 25
-3.9%
-13.9%
Q4 24
-23.1%
-6.0%
Q3 24
-10.6%
-39.5%
Q2 24
-21.2%
-12.1%
Q1 24
-37.6%
-19.3%
Net Margin
IMCR
IMCR
PRPL
PRPL
Q4 25
-2.3%
Q3 25
-0.2%
-9.9%
Q2 25
-10.5%
-16.5%
Q1 25
5.4%
-18.4%
Q4 24
-6.6%
Q3 24
10.9%
-33.1%
Q2 24
-15.4%
0.0%
Q1 24
-34.7%
-41.8%
EPS (diluted)
IMCR
IMCR
PRPL
PRPL
Q4 25
$-0.61
$0.03
Q3 25
$0.00
$0.11
Q2 25
$-0.20
$0.16
Q1 25
$0.10
$0.18
Q4 24
$-0.47
$0.08
Q3 24
$0.17
$0.36
Q2 24
$-0.23
$0.00
Q1 24
$-0.49
$0.47

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
IMCR
IMCR
PRPL
PRPL
Cash + ST InvestmentsLiquidity on hand
$864.2M
$24.3M
Total DebtLower is stronger
$126.7M
Stockholders' EquityBook value
$381.0M
$-29.7M
Total Assets
$1.1B
$296.3M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
IMCR
IMCR
PRPL
PRPL
Q4 25
$864.2M
$24.3M
Q3 25
$892.4M
$32.4M
Q2 25
$882.8M
$34.2M
Q1 25
$837.0M
$21.6M
Q4 24
$820.4M
$29.0M
Q3 24
$901.3M
$23.4M
Q2 24
$859.6M
$23.4M
Q1 24
$832.8M
$34.5M
Total Debt
IMCR
IMCR
PRPL
PRPL
Q4 25
$126.7M
Q3 25
Q2 25
Q1 25
Q4 24
$70.7M
Q3 24
$438.7M
$50.8M
Q2 24
$452.5M
Q1 24
$452.5M
Stockholders' Equity
IMCR
IMCR
PRPL
PRPL
Q4 25
$381.0M
$-29.7M
Q3 25
$396.6M
$-26.9M
Q2 25
$388.5M
$-15.6M
Q1 25
$378.5M
$1.3M
Q4 24
$360.7M
$20.2M
Q3 24
$377.8M
$28.0M
Q2 24
$359.1M
$66.4M
Q1 24
$359.5M
$65.5M
Total Assets
IMCR
IMCR
PRPL
PRPL
Q4 25
$1.1B
$296.3M
Q3 25
$1.1B
$302.1M
Q2 25
$1.1B
$303.8M
Q1 25
$1.0B
$293.8M
Q4 24
$1.0B
$307.8M
Q3 24
$1.1B
$309.3M
Q2 24
$1.0B
$362.1M
Q1 24
$994.0M
$382.1M
Debt / Equity
IMCR
IMCR
PRPL
PRPL
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
3.50×
Q3 24
1.16×
1.82×
Q2 24
1.26×
Q1 24
1.26×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
IMCR
IMCR
PRPL
PRPL
Operating Cash FlowLast quarter
$-32.7M
$-5.8M
Free Cash FlowOCF − Capex
$-35.5M
$-7.8M
FCF MarginFCF / Revenue
-34.0%
-5.5%
Capex IntensityCapex / Revenue
2.8%
1.4%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-15.1M
$-41.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
IMCR
IMCR
PRPL
PRPL
Q4 25
$-32.7M
$-5.8M
Q3 25
$-4.5M
$-968.0K
Q2 25
$26.0M
$-4.0M
Q1 25
$435.0K
$-23.1M
Q4 24
$-14.0M
$6.8M
Q3 24
$21.1M
$1.1M
Q2 24
$23.5M
$-8.9M
Q1 24
$-4.6M
$-16.8M
Free Cash Flow
IMCR
IMCR
PRPL
PRPL
Q4 25
$-35.5M
$-7.8M
Q3 25
$-5.2M
$-1.8M
Q2 25
$25.6M
$-7.0M
Q1 25
$137.0K
$-25.3M
Q4 24
$-17.5M
$5.7M
Q3 24
$20.3M
$101.0K
Q2 24
$23.1M
$-11.0M
Q1 24
$-5.0M
$-19.9M
FCF Margin
IMCR
IMCR
PRPL
PRPL
Q4 25
-34.0%
-5.5%
Q3 25
-5.0%
-1.5%
Q2 25
26.1%
-6.6%
Q1 25
0.1%
-24.3%
Q4 24
-20.9%
4.4%
Q3 24
25.3%
0.1%
Q2 24
30.7%
-9.2%
Q1 24
-7.1%
-16.5%
Capex Intensity
IMCR
IMCR
PRPL
PRPL
Q4 25
2.8%
1.4%
Q3 25
0.7%
0.7%
Q2 25
0.4%
2.8%
Q1 25
0.3%
2.2%
Q4 24
4.3%
0.8%
Q3 24
1.0%
0.9%
Q2 24
0.4%
1.7%
Q1 24
0.6%
2.5%
Cash Conversion
IMCR
IMCR
PRPL
PRPL
Q4 25
Q3 25
Q2 25
Q1 25
0.09×
Q4 24
Q3 24
2.42×
Q2 24
-330.22×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

IMCR
IMCR

Segment breakdown not available.

PRPL
PRPL

Cost Of Revenues$81.7M58%
Other$59.0M42%

Related Comparisons